We've found
3,204
archived clinical trials in
Healthy Studies
We've found
3,204
archived clinical trials in
Healthy Studies
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Updated: 3/30/2016
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated: 3/30/2016
Click here to add this to my saved trials
Normative Data of Brain Network Activation in Adolescents and Young Adults
Updated: 3/31/2016
Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents and Young Adults
Status: Enrolling
Updated: 3/31/2016
Normative Data of Brain Network Activation in Adolescents and Young Adults
Updated: 3/31/2016
Establishment of Normative Data of Brain Network Activation (BNA) Using Evoked Response Potentials in Adolescents and Young Adults
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Normative Data of Brain Network Activation
Updated: 3/31/2016
Establishment of Normative Data of Brain Network Activation Analysis (BNA) Using Evoked Response Potentials, in Adolescents and Young Adults
Status: Enrolling
Updated: 3/31/2016
Normative Data of Brain Network Activation
Updated: 3/31/2016
Establishment of Normative Data of Brain Network Activation Analysis (BNA) Using Evoked Response Potentials, in Adolescents and Young Adults
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
Updated: 3/31/2016
An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study Of 40 Mg Doses Of Pf-00345439 To Evaluate The Bioequivalence Of Modified Formulation K Vs. Original Formulation X Under Intermediate-Fat Fed Conditions And To Estimate Relative Bioavailability Under Fasting Conditions In Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
Updated: 3/31/2016
An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study Of 40 Mg Doses Of Pf-00345439 To Evaluate The Bioequivalence Of Modified Formulation K Vs. Original Formulation X Under Intermediate-Fat Fed Conditions And To Estimate Relative Bioavailability Under Fasting Conditions In Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water
Status: Enrolling
Updated: 3/31/2016
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water
Status: Enrolling
Updated: 3/31/2016
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Oral Liposomal Glutathione Supplementation in Healthy Subjects
Updated: 3/31/2016
Pilot Study of Oral Liposomal Glutathione Supplementation on Levels of Glutathione in Blood and Biomarkers of Oxidative Stress and Immune Function in Healthy Adults
Status: Enrolling
Updated: 3/31/2016
Oral Liposomal Glutathione Supplementation in Healthy Subjects
Updated: 3/31/2016
Pilot Study of Oral Liposomal Glutathione Supplementation on Levels of Glutathione in Blood and Biomarkers of Oxidative Stress and Immune Function in Healthy Adults
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
Updated: 3/31/2016
An Open-label, Randomized, Single-dose, Three-way Crossover Study to Evaluate the Dose Proportionality of 5 Mg, 20 Mg and 40 Mg of PF-00345439 Formulation K Under Intermediate-fat Fed Conditions in Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
Updated: 3/31/2016
An Open-label, Randomized, Single-dose, Three-way Crossover Study to Evaluate the Dose Proportionality of 5 Mg, 20 Mg and 40 Mg of PF-00345439 Formulation K Under Intermediate-fat Fed Conditions in Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study To Estimate The Effects Of Food On Oxycodone Pharmacokinetics Following Oral Administration Of 40 Mg Doses Of Pf 00345439 Formulation K Taken Whole Or After Chewing In Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
Updated: 3/31/2016
An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study To Estimate The Effects Of Food On Oxycodone Pharmacokinetics Following Oral Administration Of 40 Mg Doses Of Pf 00345439 Formulation K Taken Whole Or After Chewing In Healthy Volunteers
Status: Enrolling
Updated: 3/31/2016
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Volunteers
Updated: 4/2/2016
A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects
Status: Enrolling
Updated: 4/2/2016
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Volunteers
Updated: 4/2/2016
A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects
Status: Enrolling
Updated: 4/2/2016
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Volunteers
Updated: 4/2/2016
A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects
Status: Enrolling
Updated: 4/2/2016
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oseltamivir and Its Carboxylate Metabolite, RO0640802 in Healthy Volunteers
Updated: 4/2/2016
A Multiple-Center, Randomized, Double-blind, Multiple-Dose, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO0640796 (Oseltamivir) and Its Carboxylate Metabolite, RO0640802, Following Intravenous Administrations in Healthy Subjects
Status: Enrolling
Updated: 4/2/2016
Click here to add this to my saved trials
Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue
Updated: 4/4/2016
Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue
Status: Enrolling
Updated: 4/4/2016
Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue
Updated: 4/4/2016
Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials
A Study of LY3154207 on Sleep in Healthy Male Participants
Updated: 4/4/2016
An Evaluation of the Impact of Single Doses of LY3154207 on Sleep Latency in Sleep-Deprived Healthy Subjects
Status: Enrolling
Updated: 4/4/2016
A Study of LY3154207 on Sleep in Healthy Male Participants
Updated: 4/4/2016
An Evaluation of the Impact of Single Doses of LY3154207 on Sleep Latency in Sleep-Deprived Healthy Subjects
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials
A Study of AZD3293 (LY3314814) in Healthy Participants
Updated: 4/4/2016
A Bioequivalence and Food Effect Study in Healthy Subjects Administered 2 Different Tablet Formulations of AZD3293
Status: Enrolling
Updated: 4/4/2016
A Study of AZD3293 (LY3314814) in Healthy Participants
Updated: 4/4/2016
A Bioequivalence and Food Effect Study in Healthy Subjects Administered 2 Different Tablet Formulations of AZD3293
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
Updated: 4/4/2016
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of PEP005 Topical Gel (0.01% Concentration) in Healthy Volunteers Using a Repeat Insult Patch Test Design
Status: Enrolling
Updated: 4/4/2016
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
Updated: 4/4/2016
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of PEP005 Topical Gel (0.01% Concentration) in Healthy Volunteers Using a Repeat Insult Patch Test Design
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials
Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone
Updated: 4/5/2016
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone in Healthy Male Subjects After Oral Administration
Status: Enrolling
Updated: 4/5/2016
Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone
Updated: 4/5/2016
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone in Healthy Male Subjects After Oral Administration
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Sonographic Features of Normal Soft Tissues of the Feet
Updated: 4/6/2016
Sonographic Features of Normal Soft Tissues of the Feet
Status: Enrolling
Updated: 4/6/2016
Sonographic Features of Normal Soft Tissues of the Feet
Updated: 4/6/2016
Sonographic Features of Normal Soft Tissues of the Feet
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Updated: 4/6/2016
Phase 1 Open Label Safety, Acceptability, Pharmacokinetic and ex Vivo Pharmacodynamic Study of TMC278 Long Acting (LA) Administered Intramuscularly to HIV-1 Seronegative Individuals
Status: Enrolling
Updated: 4/6/2016
A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Updated: 4/6/2016
Phase 1 Open Label Safety, Acceptability, Pharmacokinetic and ex Vivo Pharmacodynamic Study of TMC278 Long Acting (LA) Administered Intramuscularly to HIV-1 Seronegative Individuals
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately
Updated: 4/7/2016
A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of Ceftazidime Avibactam (CAZ-AVI) and Metronidazole When Administered Alone and in Combination in Healthy Subjects
Status: Enrolling
Updated: 4/7/2016
A Study to Assess the Levels of CAZ-AVI and Metronidazole in the Blood When Given Together and Separately
Updated: 4/7/2016
A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of Ceftazidime Avibactam (CAZ-AVI) and Metronidazole When Administered Alone and in Combination in Healthy Subjects
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
Phase 1, Febuxostat XR Bioavailability Study
Updated: 4/11/2016
A Phase 1, Randomized, Open-Label, Single-Dose, 4-Way Crossover Study to Assess the Relative Bioavailability of Four 80 mg Febuxostat XR Formulations
Status: Enrolling
Updated: 4/11/2016
Phase 1, Febuxostat XR Bioavailability Study
Updated: 4/11/2016
A Phase 1, Randomized, Open-Label, Single-Dose, 4-Way Crossover Study to Assess the Relative Bioavailability of Four 80 mg Febuxostat XR Formulations
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants
Updated: 4/11/2016
Phase 1, Open-label, Single-dose Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Subjects
Status: Enrolling
Updated: 4/11/2016
A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants
Updated: 4/11/2016
Phase 1, Open-label, Single-dose Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Subjects
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
Multiphase Activity Promotion Study
Updated: 4/11/2016
A Social-Cognitive Smartphone Application for Improving Physical Activity in Adults
Status: Enrolling
Updated: 4/11/2016
Multiphase Activity Promotion Study
Updated: 4/11/2016
A Social-Cognitive Smartphone Application for Improving Physical Activity in Adults
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC
Updated: 4/11/2016
A Phase 1, Open-label, Parallel-group Study To Assess The Effect Of Cyp3a5 Genotype On The Pharmacokinetics Of Maraviroc And Cyp3a5-derived Metabolites With And Without Darunavir/Cobicistat In African-american And Caucasian Healthy Volunteers
Status: Enrolling
Updated: 4/11/2016
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC
Updated: 4/11/2016
A Phase 1, Open-label, Parallel-group Study To Assess The Effect Of Cyp3a5 Genotype On The Pharmacokinetics Of Maraviroc And Cyp3a5-derived Metabolites With And Without Darunavir/Cobicistat In African-american And Caucasian Healthy Volunteers
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone
Updated: 4/11/2016
A Single-Dose, 1-Period, 1-Treatment Pilot Study of an Investigational Capsule Formulation of 2 mg/.05 mg Buprenorphine/Naloxone Under Fasting Conditions
Status: Enrolling
Updated: 4/11/2016
A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone
Updated: 4/11/2016
A Single-Dose, 1-Period, 1-Treatment Pilot Study of an Investigational Capsule Formulation of 2 mg/.05 mg Buprenorphine/Naloxone Under Fasting Conditions
Status: Enrolling
Updated: 4/11/2016
Click here to add this to my saved trials
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects
Updated: 4/12/2016
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection, a Vitamin A-Coupled Lipid Nanoparticle Containing siRNA Against HSP47, in Healthy Normal Subjects
Status: Enrolling
Updated: 4/12/2016
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects
Updated: 4/12/2016
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection, a Vitamin A-Coupled Lipid Nanoparticle Containing siRNA Against HSP47, in Healthy Normal Subjects
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Updated: 4/14/2016
Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Status: Enrolling
Updated: 4/14/2016
Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Updated: 4/14/2016
Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Status: Enrolling
Updated: 4/14/2016
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients
Updated: 4/15/2016
A First-in-human Randomized, Double-blind, Placebo-controlled, 4-part Study to Assess Safety, Tolerability, Pharmacokinetics (Including Open Label Study of Food Effect and Interaction With Simvastatin) and Pharmacodynamics of Interwoven Single- and Multiple-ascending Doses of TAP311 in Healthy Subjects and Dyslipidemic Patients.
Status: Enrolling
Updated: 4/15/2016
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients
Updated: 4/15/2016
A First-in-human Randomized, Double-blind, Placebo-controlled, 4-part Study to Assess Safety, Tolerability, Pharmacokinetics (Including Open Label Study of Food Effect and Interaction With Simvastatin) and Pharmacodynamics of Interwoven Single- and Multiple-ascending Doses of TAP311 in Healthy Subjects and Dyslipidemic Patients.
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Updated: 4/15/2016
Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Status: Enrolling
Updated: 4/15/2016
Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Updated: 4/15/2016
Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Single Dose Study of PF-05230907 in Healthy Japanese Subjects
Updated: 4/20/2016
A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of An Intravenous Bolus Infusion Pf-05230907 In Healthy Japanese Subjects
Status: Enrolling
Updated: 4/20/2016
Single Dose Study of PF-05230907 in Healthy Japanese Subjects
Updated: 4/20/2016
A Phase 1, Randomized, Double-blind, Sponsor-open, Placebo-controlled, Single Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of An Intravenous Bolus Infusion Pf-05230907 In Healthy Japanese Subjects
Status: Enrolling
Updated: 4/20/2016
Click here to add this to my saved trials
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
Updated: 4/21/2016
A Randomized, Double-blinded, Placebo-controlled Study Investigating the Pharmacological Response to Celecoxib Using ex Vivo Human Whole-blood Assay (hWBA) and Broad-spectrum Lipidomics Analysis
Status: Enrolling
Updated: 4/21/2016
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
Updated: 4/21/2016
A Randomized, Double-blinded, Placebo-controlled Study Investigating the Pharmacological Response to Celecoxib Using ex Vivo Human Whole-blood Assay (hWBA) and Broad-spectrum Lipidomics Analysis
Status: Enrolling
Updated: 4/21/2016
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
Updated: 5/2/2016
Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime Administered as Single IV Doses in Healthy Human Volunteers
Status: Enrolling
Updated: 5/2/2016
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
Updated: 5/2/2016
Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime Administered as Single IV Doses in Healthy Human Volunteers
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate
Updated: 5/2/2016
An Open-Label, Randomized, Single-Dose, 2-Treatment, 2-Sequence, Crossover, Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of TR-701 (Torezolid Phosphate) in Normal Healthy Adults
Status: Enrolling
Updated: 5/2/2016
Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate
Updated: 5/2/2016
An Open-Label, Randomized, Single-Dose, 2-Treatment, 2-Sequence, Crossover, Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of TR-701 (Torezolid Phosphate) in Normal Healthy Adults
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge
Updated: 5/2/2016
A Phase 1, Blinded, Placebo-Controlled, Crossover TR-701 FA Study of Blood Pressure Response Post-Tyramine Challenge
Status: Enrolling
Updated: 5/2/2016
A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge
Updated: 5/2/2016
A Phase 1, Blinded, Placebo-Controlled, Crossover TR-701 FA Study of Blood Pressure Response Post-Tyramine Challenge
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922
Updated: 5/4/2016
An Open-Label Drug Interaction Study to Assess the Pharmacokinetics of JNJ-42847922 When Administered Alone and in Combination With Rifampin in Healthy Male and Female Subjects
Status: Enrolling
Updated: 5/4/2016
A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922
Updated: 5/4/2016
An Open-Label Drug Interaction Study to Assess the Pharmacokinetics of JNJ-42847922 When Administered Alone and in Combination With Rifampin in Healthy Male and Female Subjects
Status: Enrolling
Updated: 5/4/2016
Click here to add this to my saved trials
A Study to Evaluate of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Volunteers
Updated: 5/4/2016
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Subjects
Status: Enrolling
Updated: 5/4/2016
A Study to Evaluate of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Volunteers
Updated: 5/4/2016
A Phase 1, Open-Label Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Subjects
Status: Enrolling
Updated: 5/4/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
Updated: 5/5/2016
Long-term Follow-up Study of Subjects Who Completed Kythera-sponsored Trials of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Propofol's Hypnotic and Memory Effects
Updated: 5/5/2016
CNS Targets of Propofol's Hypnotic and Memory Effects
Status: Enrolling
Updated: 5/5/2016
Propofol's Hypnotic and Memory Effects
Updated: 5/5/2016
CNS Targets of Propofol's Hypnotic and Memory Effects
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
Updated: 5/5/2016
Phase 1, Open-Label, Crossover, Safety and Pharmacokinetic Study of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Injections in the Submental and Abdominal Areas
Status: Enrolling
Updated: 5/5/2016
To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101
Updated: 5/5/2016
Phase 1, Open-Label, Crossover, Safety and Pharmacokinetic Study of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Injections in the Submental and Abdominal Areas
Status: Enrolling
Updated: 5/5/2016
Click here to add this to my saved trials
Click here to add this to my saved trials